Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Patel Gautam
Director at Amneal Pharmaceuticals. Filing since 2 Mar 2020.
CIK 0001738054
Company
Date
Role
Action
Shares
Amount
Of holding
AMRX
Amneal Pharmaceuticals, Inc.
16 Jun 2025
Director
Sold on a plan
94,906
$761.15K
5.6%
AMRX
Amneal Pharmaceuticals, Inc.
10 Jun 2025
Director
Sold at will
56,426
$452.54K
3.2%
AMRX
Amneal Pharmaceuticals, Inc.
5 May 2025
Director
Sold at will
4,900
$39.20K
0.3%
AMRX
Amneal Pharmaceuticals, Inc.
2 May 2025
Director
Sold at will
3,768
$30.14K
0.2%
AMRX
Amneal Pharmaceuticals, Inc.
1 Apr 2025
Director
Sold at will
80,000
$664.00K
4.4%
AMRX
Amneal Pharmaceuticals, Inc.
3 Mar 2025
Director
Sold at will
80,000
$712.00K
4.2%
AMRX
Amneal Pharmaceuticals, Inc.
3 Feb 2025
Director
Sold at will
80,000
$651.20K
4.1%
AMRX
Amneal Pharmaceuticals, Inc.
8 Jan 2025
Director
Sold on a plan
62,590
$501.35K
3.1%
AMRX
Amneal Pharmaceuticals, Inc.
2 Jan 2025
Director
Sold on a plan
17,410
$139.45K
0.8%
AMRX
Amneal Pharmaceuticals, Inc.
17 Dec 2021
Director
Bought
50,000
$210.50K
23.9%
AMRX
Amneal Pharmaceuticals, Inc.
3 Mar 2020
Director
Bought
117,889
$464.48K
308%
AMRX
Amneal Pharmaceuticals, Inc.
2 Mar 2020
Director
Bought
32,111
$124.59K
526%
12 decisions on file.
